Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Human Papillomavirus Minor Capsid Protein L2 (L2) - Overview
Human Papillomavirus Minor Capsid Protein L2 (L2) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Human Papillomavirus Minor Capsid Protein L2 (L2) - Therapeutics Assessment
Assessment by Route of Administration
Assessment by Molecule Type
Human Papillomavirus Minor Capsid Protein L2 (L2) - Companies Involved in Therapeutics Development
2A Pharma AB
Papivax LLC
Pathovax LLC
Human Papillomavirus Minor Capsid Protein L2 (L2) - Drug Profiles
2AP-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PVX-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PVX-2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RGVax - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TA-CIN - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Human Papillomavirus Minor Capsid Protein L2 (L2) - Dormant Products
Human Papillomavirus Minor Capsid Protein L2 (L2) - Discontinued Products
Human Papillomavirus Minor Capsid Protein L2 (L2) - Product Development Milestones
Featured News & Press Releases
Nov 25, 2019: 2A Pharma announces the completion of dosing for 2AP01 vaccine
Mar 02, 2019: 2A Pharma initiates phase 1 clinical trial of HPV vaccine candidate
Dec 14, 2018: 2A Pharma receives approval for phase 1 study of 2AP-01
Oct 27, 2016: PathoVax Wins $500,000 in 43North Contest
Oct 30, 2014: tiol Cancer Institute supports next-generation Austrian HPV vaccine
Sep 10, 2013: New, Even More Effective HPV Vaccine In Sight
Apr 10, 2012: Medigene Presents Preclinical AAVLP Data At World Vaccine Congress
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Top 10 Indications, 2021
Number of Products by Route of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021


List of Tables


Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Indication, 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products under Investigation by Universities/Institutes, 2021
Products under Investigation by Universities/Institutes, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Pipeline by 2A Pharma AB, 2021
Pipeline by Papivax LLC, 2021
Pipeline by Pathovax LLC, 2021
Dormant Projects, 2021
Discontinued Products, 2021